| Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor | |
Yang, Wenzhe1; Yu, Xinfeng1; Zhang, Quanbin2; Lu, Qingjun3; Wang, Jing2 ; Cui, Wentong1; Zheng, Yuanyuan1; Wang, Xiaomin4; Luo, Dali1; Luo, DL
| |
| 2013-10-01 | |
| 发表期刊 | EXPERIMENTAL EYE RESEARCH
 |
| ISSN | 0014-4835 |
| 卷号 | 115页码:96-105 |
| 文章类型 | Article |
| 摘要 | Diabetic retinopathy (DR) is a hyperglycemia-induced ischemic disorder characterized by microvascular dysfunction and neovascularization. It is a leading cause of blindness in many countries, yet efficient drugs are limited now for prevention and treatment of DR. Low molecular weight fucoidan (LMWF), extract from brown algae, has been shown to possess multiple biological activities like anti-inflammation, anti-oxidation and anti-aggregation, which all could be beneficial for attenuating ischemia-induced tissue damages. Here, by comparing with calcium dobesilate, the potent antioxidant compound currently used for the treatment of DR, we investigated the protective effect of LMWF against DR in streptozotocin-induced diabetic mice and high glucose-promoted vascular endothelial growth factor (VEGF) production and cell proliferation in microvascular endothelial cells. One week after diabetes induction, the mice were administered with LMWF (50, 100 or 200 mg/kg/day) or calcium dobesilate (200 mg/kg/day) for four months, then the retinal pathological changes and neovascularization were detected by hematoxylin-eosin staining and fluorescein dextran angiography, respectively. Immunofluorescence staining, ELISA and RT-PCR were used to examine the expression levels of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and VEGF in retina and endothelial cells. Here, we found that LMWF resembled calcium dobesilate, in alleviating retinal pathological change and hindering neovascularization due to diabetes in vivo. The relative levels of VEGF expression and HIF-1 alpha induction were also less in retinas of LMWF- or calcium dobesilate-treated diabetic mice than those in retinas of control mice. Furthermore, high glucose-induced VEGF overexpression and cell proliferation in primary cultured vascular endothelial cells were also inhibited by LMWF in a dose-dependent manner. Therefore, this study demonstrated that LMWF alleviates diabetic retinal neovascularization and damage likely through lowering HIF-1 alpha and VEGF expressions, providing a potential candidate drug for prevention and treatment of diabetic retinopathy. (C) 2013 Elsevier Ltd. All rights reserved.; Diabetic retinopathy (DR) is a hyperglycemia-induced ischemic disorder characterized by microvascular dysfunction and neovascularization. It is a leading cause of blindness in many countries, yet efficient drugs are limited now for prevention and treatment of DR. Low molecular weight fucoidan (LMWF), extract from brown algae, has been shown to possess multiple biological activities like anti-inflammation, anti-oxidation and anti-aggregation, which all could be beneficial for attenuating ischemia-induced tissue damages. Here, by comparing with calcium dobesilate, the potent antioxidant compound currently used for the treatment of DR, we investigated the protective effect of LMWF against DR in streptozotocin-induced diabetic mice and high glucose-promoted vascular endothelial growth factor (VEGF) production and cell proliferation in microvascular endothelial cells. One week after diabetes induction, the mice were administered with LMWF (50, 100 or 200 mg/kg/day) or calcium dobesilate (200 mg/kg/day) for four months, then the retinal pathological changes and neovascularization were detected by hematoxylin-eosin staining and fluorescein dextran angiography, respectively. Immunofluorescence staining, ELISA and RT-PCR were used to examine the expression levels of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and VEGF in retina and endothelial cells. Here, we found that LMWF resembled calcium dobesilate, in alleviating retinal pathological change and hindering neovascularization due to diabetes in vivo. The relative levels of VEGF expression and HIF-1 alpha induction were also less in retinas of LMWF- or calcium dobesilate-treated diabetic mice than those in retinas of control mice. Furthermore, high glucose-induced VEGF overexpression and cell proliferation in primary cultured vascular endothelial cells were also inhibited by LMWF in a dose-dependent manner. Therefore, this study demonstrated that LMWF alleviates diabetic retinal neovascularization and damage likely through lowering HIF-1 alpha and VEGF expressions, providing a potential candidate drug for prevention and treatment of diabetic retinopathy. (C) 2013 Elsevier Ltd. All rights reserved. |
| 关键词 | Low Molecular Weight Fucoidan Diabetic Retinopathy Vascular Endothelial Growth Factor Vascular Endothelial Cells High Glucose Hypoxia-inducible Factor-1 Alpha |
| 学科领域 | Ophthalmology |
| DOI | 10.1016/j.exer.2013.06.011 |
| URL | 查看原文 |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS研究方向 | Ophthalmology |
| WOS类目 | Ophthalmology |
| WOS记录号 | WOS:000326060600013 |
| WOS关键词 | CALCIUM DOBESILATE ; EYE DISEASE ; EXPRESSION ; CELLS ; ANGIOGENESIS ; RATS ; POLYSACCHARIDES ; PROLIFERATION ; MODULATION ; MIGRATION |
| WOS标题词 | Science & Technology ; Life Sciences & Biomedicine |
| 引用统计 | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.qdio.ac.cn/handle/337002/16685 |
| 专题 | 海洋生物技术研发中心 |
| 通讯作者 | Luo, DL |
| 作者单位 | 1.Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing 100069, Peoples R China 2.Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China 3.Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China 4.Capital Med Univ, Dept Physiol, Beijing 100069, Peoples R China |
| 推荐引用方式 GB/T 7714 | Yang, Wenzhe,Yu, Xinfeng,Zhang, Quanbin,et al. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor[J]. EXPERIMENTAL EYE RESEARCH,2013,115:96-105. |
| APA | Yang, Wenzhe.,Yu, Xinfeng.,Zhang, Quanbin.,Lu, Qingjun.,Wang, Jing.,...&Luo, DL.(2013).Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.EXPERIMENTAL EYE RESEARCH,115,96-105. |
| MLA | Yang, Wenzhe,et al."Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor".EXPERIMENTAL EYE RESEARCH 115(2013):96-105. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| Attenuation of strep（3734KB） | 限制开放 | CC BY-NC-SA | 浏览 | |||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论